Circular RNA hsa_circ_0008285 inhibits colorectal cancer cell proliferation and migration via the miR-382-5p/PTEN

Jianjun Wang1, Juanjuan Luo2, Gan Liu3

  • 1Department of Histology and Embryology, Wannan Medical College, Wuhu, 241002, China.

Insights

Circular RNA hsa_circ_0008285 is downregulated in colorectal cancer (CRC), promoting tumor growth. It suppresses the PI3K/AKT pathway via miR-382-5p/PTEN, indicating its potential as a CRC therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are implicated in various cancers, but their specific roles and mechanisms in colorectal cancer (CRC) remain underexplored.
  • Hsa_circ_0008285 (circ_0008285), derived from the CDYL gene, shows differential expression in cancers, being upregulated in some but reduced in colon cancer.

Purpose of the Study:

  • To investigate the function and molecular mechanism of circ_0008285 in the progression of colorectal cancer (CRC).
  • To evaluate circ_0008285 as a potential therapeutic target for CRC.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) to confirm circ_0008285 expression in CRC tissues and cell lines.
  • Clinicopathological analysis to correlate circ_0008285 levels with tumor progression.
  • In vitro functional assays (e.g., knockdown) to assess effects on CRC cell proliferation and migration.
  • RNA-sequencing, bioinformatics, dual-luciferase reporter assays, and western blotting to elucidate the underlying molecular mechanism.

Main Results:

  • Circ_0008285 expression was significantly downregulated in CRC tissues and cell lines compared to normal controls.
  • Lower circ_0008285 levels correlated inversely with tumor size, lymphatic metastasis, and TNM stage.
  • Knockdown of circ_0008285 enhanced CRC cell proliferation and migration in vitro.
  • Mechanistically, circ_0008285 was found to suppress the PI3K/AKT signaling pathway through the miR-382-5p/PTEN axis.

Conclusions:

  • Circ_0008285 acts as a tumor suppressor in colorectal cancer.
  • The findings suggest that circ_0008285 could be a potential diagnostic biomarker and therapeutic target for CRC treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K